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Harnessing Macrophages for
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Lessons From Microbes
Johan Georg Visser, Anton Du Preez Van Staden* and Carine Smith*
Department of Physiological Sciences, Stellenbosch University, Matieland, South Africa
With the effectiveness of therapeutic agents ever decreasing and the increased
incidence of multi-drug resistant pathogens, there is a clear need for administration
of more potent, potentially more toxic, drugs. Alternatively, biopharmaceuticals may
hold potential but require specialized protection from premature in vivo degradation.
Thus, a paralleled need for specialized drug delivery systems has arisen. Although
cell-mediated drug delivery is not a completely novel concept, the few applications
described to date are not yet ready for in vivo application, for various reasons such
as drug-induced carrier cell death, limited control over the site and timing of drug
release and/or drug degradation by the host immune system. Here, we present our
hypothesis for a new drug delivery system, which aims to negate these limitations. We
propose transport of nanoparticle-encapsulated drugs inside autologous macrophages
polarized to M1 phenotype for high mobility and treated to induce transient phagosome
maturation arrest. In addition, we propose a significant shift of existing paradigms in the
study of host-microbe interactions, in order to study microbial host immune evasion and
dissemination patterns for their therapeutic utilization in the context of drug delivery. We
describe a system in which microbial strategies may be adopted to facilitate absolute
control over drug delivery, and without sacrificing the host carrier cells. We provide a
comprehensive summary of the lessons we can learn from microbes in the context
of drug delivery and discuss their feasibility for in vivo therapeutic application. We then
describe our proposed “synthetic microbe drug delivery system” in detail. In our opinion,
this multidisciplinary approach may hold the solution to effective, controlled drug delivery.
Keywords: synthetic microbe, expulsion, cell-mediated delivery, biopharmaceutical, phagocytosis, intracellular
pathogen, polymer, nano-medicine
INTRODUCTION
In recent years, drug delivery has become a well-documented research niche across various
disciplines in science. Approaches of drug delivery into pathogenically damaged areas or poorly
vascularised cancer tissues has been largely focused on treatments incorporating nanoparticles
(Zhao et al., 2011; Dreaden et al., 2012; Feng et al., 2014; Huang et al., 2015; Lv et al., 2016; Tanei
et al., 2016). These nanoparticles generally serve to shield harsh/labile drugs from the host and
subsequently activate or release it after reaching target tissues. With the potential exception of
nanoparticle uptake into target cells via complementary receptor ligands, this approach is, however,
still more comparable to drug saturation than with specialized drug delivery per se.
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In this review we propose an alternative to
the strategies/approaches used until now: a novel
macrophage-mediated drug delivery method that more
accurately fits the term “drug delivery,” via incorporation of
both nanomedicine and cellular manipulation. Macrophages
are highly mobile cells. By loading host macrophages with
appropriate “cargo” (e.g., chemotherapeutic agents such
as doxorubicin or high-potency antimicrobials), one can
thus theoretically use the inherent homing capabilities
of these immune cells to reach target damaged, infected
or malignant tissue, in order to treat the affected cellular
areas only. Such an approach would reduce the total
concentration of drug required (when compared to systemic
administration) and significantly reduce or even eradicate the
risk of drug-associated adverse effects. Achieving this goal
would indeed require substantial research into phagocytosis,
macrophage chemotaxis, pathogenic immune evasion and
controlled release of therapeutics. Here, we propose such a
system where “cargo” is introduced into the macrophage,
maintained within “inactivated” phagosomes and released
in a controlled manner at the appropriate time and in vivo
location.
The system as proposed in its entirety here, is novel.
However, some aspects of this system have been investigated
individually before (discussed in detail in Section “The
Impossible Made Possible?”) and testifies to the feasibility
of the approach we suggest. In order to fully understand
cellular role players, a multidisciplinary approach is clearly
required. We propose that the literature on host–microbe
interactions may provide the insight required. While research
has described the ability of microbes to evade the immune
system by hiding (and proliferating) inside immune cells before
orchestrating their own expulsion or transfer directly into
new host cells, the mechanisms by which they achieve this
have received very little attention by non-microbiologists. In
our opinion, harnessing these microbial strategies could prove
useful in the drug delivery niche. Thus, if a paradigm shift
can be made to embrace the fact that host-affecting microbial
mechanisms may potentially have therapeutic application, we
believe that biologists could learn valuable lessons from
microbes, to the benefit of technological advancement in
medicine.
The aim of this paper is therefore to present a summary of
pertinent literature on microbial mechanisms known to modulate
the course of endocytic processes and to evaluate their feasibility
in the context of therapeutic drug delivery. A specific novel
focus will be on potential mechanisms through which to achieve
controlled expulsion. We believe that this paper elucidates
an exciting new avenue for research in the context of drug
delivery.
In order to facilitate clarity of our argument, we first provide
a brief overview of the most pertinent literature describing the
mechanisms that would come into play in a complete cell-based
delivery system. Considering the complexity of these processes,
one can appreciate the enormity of the task to elucidate which
perturbations in this process may be used for application to
our proposed drug delivery system. Thus, we will describe the
different phases – namely cargo loading, maintenance of cargo
integrity, in vivo motility of the carrier cell toward delivery sites
and cargo expulsion – individually below, before discussing in
more detail, the lessons to be learnt from microbes.
COMPONENTS OF A CELL-BASED
DELIVERY SYSTEM
Cargo Loading Into Macrophages
Circulating monocytes form part of the innate immune system
and are largely responsible for the initial recognition of foreign
material or microbes (Abbas et al., 2014). Recognition and
internalization, for the purpose of neutralization, are generally
very effective. This is evidenced by the absence of adaptive B
and T cell responses in almost 95% of Animalia (Mills et al.,
2015). However, many microbes have been able to survive within
macrophages by manipulating phagocytic processes (discussed
later in Section “What Can We Learn From Microbes?”).
A summary of the most relevant normal human phagocytic
processes is presented visually in Figure 1.
The most important aspect of our topic, is that of immune
recognition and uptake into the macrophage. It is commonly
known that pattern recognition receptors (PRRs) on phagocytes
recognize several different molecular patterns – such as damage-
associated molecular patterns (DAMPs) or pathogen-associated
molecular patterns (PAMPs) – on the target for potential
phagocytosis (Abbas et al., 2014). Toll-like receptors (TLRs)
present on phagocytes also indirectly regulate phagocytosis
through Myeloid differentiation primary response 88 (Myd88)
signaling and activation of the p38 residue (Shi et al., 2016).
Several other minor role players in pathogen recognition, such
as receptors for lectin, mannose, complement and Retinoic acid-
inducible gene-I-like (RIG-like) receptors, have been identified,
but the immunoglobulin G (IgG) receptors are most directly
associated with phagocytosis of material. In fact, antibody-
opsonised material binds and activates IgG receptors to induce
engulfment independently of co-stimulation by T cells or NK
(natural killer) cells (Liu et al., 2013), making this mechanism
an obvious choice for ex vivo cargo loading into macrophages.
Engulfment is reliant on phosphoinositide 3-kinase (PI3k)
recruitment and its production of various phosphatidylinositides
that, together with actin polymerization, result in pseudopod
formation around the material and subsequent internalization.
Once material has been engulfed, it is enveloped inside a
double-membraned (nascent) phagosome, which is innocuous
and undergoes various maturation phases, that culminates in
fusion with lysosomes, which enables it to acidify and break
down its contents. Characterization of the engulfment and early
maturation processes is well-established (Patki et al., 1998; Fratti
et al., 2001; Vieira et al., 2002, 2003; Kinchen et al., 2008; Fairn
and Grinstein, 2012) and are not discussed in more detail here,
as we do not envisage a requirement for huge manipulation of
this phase. Indeed, previous research by our group and others
have demonstrated that macrophages readily take in a variety
of purpose-designed materials and particles of varying sizes via
endocytic pathways (Muthana et al., 2011; Zhao et al., 2011;
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FIGURE 1 | Fundamental mechanisms of phagosome maturation. Initiated
through (1) Recognition and engulfment of opsonised microbe and expression
of phospholipids and phosphoinositide 3-kinase (PI3k), at the extending
pseudopodia. (2) Nascent phagosome is formed after actin polymerization
facilitates pseudopod closure behind the microbe. This phagosome is
characterized by Rab5, phosphatidylinositol 3-phosphate (PI3P) and
endosomal early antigen 1 (EEA1) expression. (3) The late phagosome is
characterized by Rab7 recruitment; resulting in Rab5 inactivation and PI3P
degradation as well as recruitment of lysosome-associated membrane
proteins (LAMP) while achieving dynein linkage and centripetal movement for
later lysosomal fusion. Rab7 achieves these processes via
Rab7-interacting-lysosomal-protein (RILP) and oxysterol-binding protein
related-protein 1 (ORP1L). Lysosome fusion initiates the last stage in
maturation; (4) Phagolysosome biogenesis, where LAMP expression is
increased and lysosomal content is dumped into the phagosome. Rab20 also
allows an acidic environment through the action of vacuolar-type H+-ATPase
(V-ATPase).
Dreaden et al., 2012; Feng et al., 2014; Oh and Park, 2014; Huang
et al., 2015; Miller et al., 2015; Tanei et al., 2016; Fan et al., 2018;
Visser and Smith, 2018).
Cargo Maintenance
Of more direct relevance, lysosomal fusion marks the start of
the last stage in maturation, that of phagolysosome biogenesis
(Seto et al., 2011), which is an obvious threat to cargo
maintenance. Normally, this lysosome fusion is mediated by
endoplasmic reticulum (ER) soluble N-ethylmaleimide-sensitive
factor-attachment proteins (SNARE) such as syntaxin 7, syntaxin
8 and vesicle associated membrane protein (VAMP) -7 and -8
(Becken et al., 2010). Lysosome-associated membrane protein
(LAMP) concentration is increased after fusion (Jahraus et al.,
1994) and cathepsin D proteases are recruited from the Golgi
via Rab-22b, -32, -34, -38, and -43 (Ng et al., 2007). The
vacuolar-type H+-ATPase (V-ATPase) is also incorporated via
Rab20 co-localization at this time (Curtis and Gluck, 2005).
In this way, fusion ultimately effectuate an acidic environment
within the macrophage phagosome, as well as supplying it with
proteases, reactive oxygen species (ROS) and reactive nitrogen
species (RNS) to facilitate decomposition of phagosomal content.
To date, the majority of literature employing macrophages
as delivery shuttles, have used either nanoparticle-encapsulated
drugs traveling inside the cell, or drugs “backpacked” on the
outside of the cell. The most popular protocol used is loading
cargo into macrophages to create a “Trojan horse.” However, this
approach has some limitations: firstly, there is a significant risk
of drug-associated cytotoxicity, secondly, drugs are released at a
relatively slow rate and thirdly, they are vulnerable to lysosomal
degradation inside the macrophage (Yousefpour and Chilkoti,
2014). In an attempt to address these limitations, transport of
drugs on the outer surface of macrophages were attempted.
However, prevention of internalization of the backpacked cargo
into carrier macrophages was a major obstacle (Holden et al.,
2010; Doshi et al., 2011).
In our opinion, perhaps the most feasible option to ensure
integrity of cargo that are either labile or highly toxic – so
that premature delivery should not be risked – would be
their maintenance intracellularly by modification of normal
phagocyte function. It is here where we could substantially
learn from microbial strategies (refer to Section “What Can
We Learn From Microbes?”). Indeed, we have previously
demonstrated maintenance of cargo inside primary human
M1 macrophages chemically treated to transiently inhibit
phagosomal cargo destruction (Visser and Smith, 2018). Briefly,
protein-coated polystyrene beads, used as simulative cargo, were
maintained intact (i.e., with no digestion of the protein coating)
inside macrophages after in vitro treatment with a phagosome
maturation inhibiting cocktail, consisting of Wortmannin,
Concanamycin A and Chloroquine. This inhibition cocktail
was only administered in vitro, and treated cells were washed
prior to use, thus lowering risk to patient in the context of
in vivo application. Furthermore, this intervention did not affect
chemotactic or migratory capacity – macrophages were able to
transverse an in vitro Human Umbilical Vein Endothelial Cell
(HUVEC) membrane while carrying the bead cargo.
Another modern technique relevant here, is the use of
nano- or microparticle encapsulation of drugs prior to loading
into carrier cells (Dou et al., 2006; Zhao et al., 2011; Chang
et al., 2013; Blaudszun et al., 2014; Feng et al., 2014; Gnanadhas
et al., 2017; Klyachko et al., 2014; Pang et al., 2016; Tanei
et al., 2016; Evans et al., 2018; Fan et al., 2018). In addition
to host protection, polymeric particles may also be used for
maintenance of drug integrity itself. Emerging evidence indeed
indicates a role for polymeric particles as protective modality
for both host and drug cargo. Cargo can be rendered innocuous
via, for example, poly-(NIPA-co-AAm) (PNIPAAm) micelle or
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microbubble encapsulation. PNIPAAm micelles are reported to
degrade in response to an increase in temperature above the lower
critical solution temperature (Feng et al., 2014), enabling control
over bio-activation of encapsulated drugs. As an example, these
micelles could be incorporated during treatment of peripheral
diseases, such as melanoma or myopathy, where an external
stimulus can be administered to increase the local temperature
and release drug cargo from PNIPAAm micelles. Incorporation
of microbubbles together with nanoparticles has also shown some
promise during in vivo delivery of resveratrol for treatment of
cancer (Lv et al., 2016). In this study, resveratrol was loaded into
acetylated β-cyclodextrin nanoparticles (PNP), which were then
loaded into microbubbles. The outer microbubble coating served
to protect the pH sensitive PNP while in circulation, whereas
PNP in turn released resveratrol upon exposure to the low pH
tumor niche. These studies indicate that polymeric particles may
be powerful tools to incorporate into delivery systems to address
current limitations.
In vivo Macrophage Migration for Cargo
Delivery
Literature focusing on macrophage (or other phagocyte)
migration are normally aimed at the prevention of this migration,
e.g., in the context of cancer metastasis or inflammation. Despite
the different focus to ours, these studies have elucidated the
process of migration in detail.
For example, in the context of muscle inflammation, M1
macrophages have been illustrated to be the most motile,
pro-inflammatory phenotype, while M2 macrophages are less
likely to infiltrate tissues and associated with a relatively anti-
inflammatory outcome (Arnold et al., 2007; Smith et al.,
2008; Kruger et al., 2014). Our previous work on M1
macrophages (Visser and Smith, 2018) confirms the choice
of this phenotype as superior for drug delivery. However, it
should be noted that macrophage phenotype has a large degree
of plasticity, which will have to be taken into account when
designing drug delivery protocols for application in particular
disease states. To this end, a recent review (Ruytinx et al.,
2018) comprehensively provide information on macrophage
polarization in the context of inflammatory diseases such
as neurological disease, cancer, metabolic and cardiovascular
disorders.
Similarly, in terms of chemotactic signals for macrophage
migration, chemotaxins generally expressed on tissue cells in
many different disease conditions have been identified. Most
notably, inflammation – which would be present in any disease
state with a requirement for drug delivery – is known to result
in increased levels of the chemokines macrophage migration
inhibitory factor (MIF) and/or macrophage chemotactic protein
(MCP-1 or CCL2), which are strong signals for macrophage
recruitment into the tissue (Lee et al., 2010; Baeck et al., 2012).
Additionally, oxidative stress – which is a known complication of
both chronic disease and infection (Nimse and Pal, 2015; Petersen
and Smith, 2016) – have been shown to initiate macrophage
migration in vivo (Wang et al., 2016). In terms of systemic
migration toward chemotactic signals originating from hypoxic
tissue, such as in cancer, evidence also exist to confirm the
inherent capacity of macrophages to migrate toward tumors
(Owen et al., 2004; Batrakova et al., 2011). Although finer
detail on the regulation of macrophage migration has been
reported, such as its dependence on integrin β1 expression
and recycling (Lee et al., 2017) and numerous proteases (Van
Goethem et al., 2018), these details are likely of academic value
only, at least for the context under discussion. In our opinion,
these factors are unlikely to be a limiting factor, since integrin
β1 is expressed by almost all cell types and some degree of
redundancy is in place. For example, in contrast to the fairly
uniform amoeboid movement of neutrophils, macrophages were
reported to exhibit multiple different migration mechanisms that
are more mesenchymal in nature (Barros-Becker et al., 2017;
Van Goethem et al., 2018), which could confer greater resilience
to macrophages in terms of mobility under adverse conditions.
Interestingly, the latter study also demonstrated a larger degree
of directionality of macrophages vs. neutrophils in a zebrafish
tail transection model of leukocyte migration. Another ability
of macrophages pertinent to the current topic, is their ability
to maintain their mobility after ingestion of cargo, even when
the cargo is much larger than anticipated to be required for the
purpose of drug delivery (Chang et al., 2013; Evans et al., 2018;
Visser and Smith, 2018). These reports again confirm that this
phase of the system is unlikely to require major intervention, as it
seems to already have been fine-tuned by evolution.
The only potential limitation we foresee is interference with
chemotactic signal originating from the intended site for drug
delivery, by e.g., an acute, severe infection/damage in another
organ, which may have chemotactic priority above that of the
signal originating from the intended delivery site. However, the
practice of isolating patients for a period prior to a medical
procedure is not uncommon and could avoid this complication.
Furthermore, pathogen-associated infection has been shown
to take priority above other, relatively less life-threatening,
situations, which would in fact favor directional macrophage
migration, rather than limit it.
Cargo Expulsion
The final step to complete such a delivery system, would
be a mechanism by which the cargo can be released or
expelled at the appropriate time and location in vivo. Normally,
following phagolysosomal destruction of ingested material,
digested material is either recycled by the phagocytic cell or
expelled into the extracellular matrix. Recycling of re-usable
“waste” such as amino acids, glucose and phosphates occur
via diffusion through the phagolysosome membrane into the
cytosol (Guyton and Hall, 2011). Of particular interest here,
the insoluble components are expelled from the macrophage
either via the ER-Golgi secretory pathway or utilized for antigen
presentation through Ca2+- and vesicle-associated membrane
protein 7 (VAMP7)-dependant lysosome exocytosis (Samie and
Xu, 2014). We believe that the manipulation of these expulsion
mechanisms could facilitate controlled drug delivery.
In terms of published studies on drug delivery systems,
most systems either rely on non-specific release of nanoparticles
containing drugs (Miller et al., 2015), or employ release
of drugs inside the carrier cell. For example, rupture of
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doxorubicin-containing microbubbles inside macrophages was
achieved by high intensity focused ultrasound techniques
(Fan et al., 2018). However, this strategy for drug release
resulted in significant carrier cell death. We believe this is
an undesirable mechanism, as this would likely contribute to
inflammation and thus delayed recovery. Therefore, to date,
a controlled cell-based drug release system does not seem to
exist.
In the next section, we evaluate microbially employed
strategies, in terms of their feasibility for adaptation into
therapeutic contexts. We will focus on the two phases
of this system which seems to be most commonly and
effectively manipulated by microbes, namely immune evasion
by intracellular survival and programmed expulsion from host
cells.
WHAT CAN WE LEARN FROM
MICROBES?
Pathogenic phagosome maturation arrest or modulation
thereof, and subsequent excape from the host cell are hallmarks
of bacterial host immune evasion and dissemination. Well
characterized mechanisms include interfering with PI3k and
PI3P biogenesis (Mycobacterium tuberculosis and Candida
glabrata) (Vergne et al., 2003; Rai et al., 2015), establishing
microbe-containing vacuoles (Legionella pneumophila and
Brucella) (Celli, 2015; Bärlocher et al., 2017), blocking of fission
and fusion with lysosomes and endosomes (Mycobacterium
tuberculosis and Legionella) (Vergne et al., 2003, 2005;
Bärlocher et al., 2017), raising pH levels via induction of
phagosomal acid leakage (Cryptococcus neoformans) (Tucker
and Casadevall, 2002), lysis of the phagosomal membrane
(Listeria monocytogenes) (Alberti-Segui et al., 2007), hijacking
of the endocytic recycling pathway (Legionella pneumophila)
(Xu and Luo, 2013) and even active macrophage killing
(filamentous Candida albicans) (Gaur et al., 2013). Manipulation
of the endocytic pathways by microbes is achieved via highly
diverse and complex mechanisms. Intracellular microbes
secrete hundreds of proteins, known as effectors, capable of
modulating these pathways (Santos et al., 2015; Schroeder,
2018). These effectors have diverse functions and microbes
employ multiple layers of redundancy to ensure their survival
(Ghosh and O’Connor, 2017; Schroeder, 2018). The abundance
and variety of these effectors provide an ideal bioprospecting
opportunity to identify effectors that can be utilized to modulate
the endocytic pathways as needed. Keeping in mind that not
all microorganisms have effectors capable of manipulating
the endocytic pathway for both maintenance and expulsion.
Identified effectors can then be further investigated to optimize
the cocktail of effectors (possibly from different organisms)
best suited for application in a macrophage-based delivery
system.
Examples of intracellular microbes and their mechanisms for
modulation of the endocytic pathway are summarized in Table 1.
In order to provide more detail on the variety and complexity
of methods used, modulatory mechanisms of different microbes
in the context of both phagosome maturation and expulsion are
presented in the next sections.
Intracellular Survival Mechanisms
Due to the high incidence of tuberculosis in especially developing
countries, much research has been focused on the causative
agents of this illness. As a result, relatively detailed knowledge
is available on the route of immune evasion by this pathogen
in particular, as well as on how bacterially secreted effectors
and cell wall components modulate phagosome maturation. The
primary route of Mycobacterium tuberculosis (Mtb) into the
body is through inhalation, where it reaches the lungs’ alveolar
space and is preferentially taken up by alveolar macrophages.
Mtb survive intracellularly by working against PI3ks to prevent
EEA1 docking. This is achieved in two ways: (1) Mtb secretes
a PI 3′-phosphatase (SapM) that dephosphorylates PI3P and
(2) a component in the microbial cell wall, lipoarabinomannan
(LAM), interferes with recruitment/activation of the human
PI3k (hVPS34) (Vergne et al., 2005). Mycobacterium-containing
phagosomes also retain the tryptophan-aspartate containing
coat (TACO) protein (normally expressed on the cytosolic
leaflet of the plasma membrane and involved in intracellular
membrane trafficking, cytokinesis and cytoskeletal remodeling)
(Ferrari et al., 1999). TACO retention causes prolonged Rab5
expression – although some maturation effectors can still bind
the phagosome, this effectuates a relative absence of PI3P, so
that the FYVE domain-mediated binding of EEA1 is greatly
perturbed (Simonsen et al., 1998) and lysosome fusion inhibited
(Ferrari et al., 1999). Additionally, secretion of the soluble
serine/threonine kinase Protein kinase G (PKG) by Mtb into the
host cytosol is essential for prevention of phagosome-lysosome
fusion (Walburger et al., 2004). Furthermore, a more alkaline
and hydrolase deficient phagosome is also brought about in
two ways. Firstly, hydrolysis is weakened by limited expression
of Rab7. This GTPase has been shown to only transiently
localize to mycobacterial phagosomes, preventing sufficient
Rab7-interacting lysosomal protein (RILP) recruitment, but also
limiting cathepsin D protease delivery (Seto et al., 2010, 2011).
Secondly, acidification is regulated by Mtb by interfering with
V-ATPase complex assembly and retention, thereby maintaining
a stable, slightly alkaline pH (6.2–6.5) (Sturgill-Koszycki et al.,
1994; Seto et al., 2011; Queval et al., 2017). The Mtb phosphatase,
PtpA, is involved in inhibition of complex assembly by binding
to the subunit H of the V-ATPase where it then dephosphorylates
and inactivates hVPS33B, effectively inhibiting the membrane
fusion machinery (Wong et al., 2011).
In contrast to Mtb, the survival mechanisms of C. glabrata
is largely dependent on active PI3ks. C. glabrata encodes the
enzyme PI3k and produces fungal PI3P (Strahl and Thorner,
2007; Rai et al., 2015). In this manner, the PI3P content of
phagosomes increase prematurely during the early stages of
maturation, where PI3P has not yet come into play. This could
lead to a PI3P rich phagosome being identified as already partly
matured, thus halting further maturation. Additionally, increased
PI3P content could overburden PI3P degradation capacity of
the phagosomal lumen. Deletion of the functional subunits
of fungal PI3k led to ameliorated phagosome maturation and
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TABLE 1 | Examples of intracellular microbes and main outcomes of endocytic pathway modulation.
Organism Disease state Type of endocytic
modulation
Outcome of endocytic
modulation
Egress and
dissemination
Brucella (G-)
∗ 1
Brucellosis/Malta Fever Modulation of phagosome
maturation
VirB (T4SS) dependent
modulation of phagosome,
Suppression of
macrophage polarization
Cell necrosis/apoptosis
(VirB and bacterial
dissociation dependent)
followed by extracellular
dissemination
Legionella pneumophila (G-)
∗ 2
Legionnaires disease Prevention of phagosome
maturation
Dot/Icm (T4BSS)
dependent prevention of
phagosome maturation
Pyroptosis, Apoptosis, Cell
lysis
Listeria monocytogenes
(G+)
∗ 3
Listeriosis Prevention of phagosome
maturation, phagosome
rupture
Listeriolysin-O dependent
lysis of phagosome or
induction of autophagy for
replication
Cell-to-cell spread
(ActA/LLO-dependent)
Chlamydia (G-)
∗ 4
Genital/respiratory infections Subversion of endocytic
pathway via inclusion
formation
Inc/CT229 dependent
inclusion development
Cell lysis, Inclusion
extrusion
Mycobacterium
tuberculosis (acid fast)
∗ 5
Tuberculosis Prevention of phagosome
maturation, phagosome
rupture
LAM/SapM dependent
interference of PI3k and
PI3P biogenesis. Inhibition
of H+ V-ATPase assembly.
ESX-1/EsxA and PDIM
dependent phagosome
rupture
Cell necrosis/apoptosis
Salmonella enterica (G-)
∗ 6
Salmonellosis Modulation of phagosome
maturation
Modulation of phagosome
maturation via T3SS
effector (SifA, SopB)
dependent development of
SCV
Pyroptosis
Cryptococcus neoformans
(Yeast)
∗ 7
Cryptococcal meningitis Unknown effectors.
Possible pH dependent
phagosome damage.
Capsular protection.
Unknown effectors.
Possible pH modulation
through phagosome
damage.
Non-lytic expulsion, cell
lysis, cell-to-cell spread
Gram negative (G−), Gram positive (G+). ∗1: Pizarro-Cerdá et al., 1998; Hong et al., 2000; Comerci et al., 2001; Boschiroli et al., 2002; Celli et al., 2003, Celli, 2006,
2015; Arellano-Reynoso et al., 2005; Pei et al., 2008, 2006, 2014; Starr et al., 2008, 2012; Chen and He, 2009; Chen et al., 2011; Von Bargen et al., 2012; Smith et al.,
2016. 2: Kirby et al., 1998; Roy et al., 1998; Gao and Abu Kwaik, 1999; Alli et al., 2000; Gerhardt et al., 2000; Bachman and Swanson, 2001; Tilney et al., 2001; Molmeret
et al., 2002, 2004; Chen et al., 2004, 2007; Xu and Luo, 2013; Schroeder, 2018. 3: Smith et al., 1995; Veiga and Cossart, 2005; Henry et al., 2006; Shaughnessy et al.,
2006; Alberti-Segui et al., 2007; Birmingham et al., 2008; Czuczman et al., 2014; Mitchell et al., 2015; Skoble et al., 2017. 4: Perfettini et al., 2003; Scidmore et al.,
2003; Rzomp et al., 2003; Hybiske and Stephens, 2007; Betts-Hampikian and Fields, 2010; Capmany and Damiani, 2010; Chin et al., 2012; Volceanov et al., 2014. 5:
Sturgill-Koszycki et al., 1994; Ferrari et al., 1999; Renshaw et al., 2002; Walburger et al., 2004; Vergne et al., 2005; de Jonge et al., 2007; Seto et al., 2010, 2011; Wong
et al., 2011; Simeone et al., 2015; Zhang et al., 2016; Augenstreich et al., 2017; Queval et al., 2017; Quigley et al., 2017. 6: Hersh et al., 1999; Steele-Mortimer et al.,
1999; Jesenberger et al., 2000; Sano et al., 2007; Bujny et al., 2008; Mallo et al., 2008; Bakowski et al., 2010; Braun et al., 2010; McGourty et al., 2012; Chakraborty
et al., 2015; D’Costa et al., 2015; LaRock et al., 2015; Li et al., 2016; Knuff and Finlay, 2017. 7: Wozniak and Levitz, 2008; Johnston and May, 2010; Nicola et al., 2011,
2012; Qin et al., 2011; Chen et al., 2015; Davis et al., 2015; Smith et al., 2015; Bojarczuk et al., 2016; Gilbert et al., 2017.
significantly reduced fungal survival and virulence (Rai et al.,
2015). The differences between the strategy of C. glabrata vs. Mtb
illustrates how the same cellular role players may be modulated in
different ways for different outcomes, depending on the intended
requirement of the modulating microbe, and in our opinion
also demonstrates the susceptibility of this system to exogenous
modulation or control.
Reminiscent of Mtb, Leishmania (the causative agent of
Leishmaniasis) promastigotes are also harbored in phagosomes
that retain TACO on their membranes, blocking lysosome
fusion and ensuring a neutral pH in which this parasite can
differentiate into the amastigote stage (Ferrari et al., 1999;
Gogulamudi et al., 2015). However, after differentiation, the
parasite allows phagosome fusion with lysosomes to achieve an
acidic environment in which the amastigotes thrive. Interestingly,
these phagosomes still exhibit low expression of late phagosomal
markers (LAMP, V-ATPase and Rab7), after lysosome fusion
(Vinet et al., 2009). In addition, Leishmania protects itself by
inhibiting recruitment of NADPH oxidase to the phagosome,
perturbing ROS production (Moradin and Descoteaux, 2012).
Similarly, M. tuberculosis was reported to stimulate release of
TNF-α and IL-10 from infected macrophages (Sendide et al.,
2005), resulting in a deactivation of ROS and RNS release
(Redpath et al., 2001). IL-10 specifically down-regulates secretion
of pro-inflammatory cytokines (Redpath et al., 2001) like INF-γ
and TNF-α and results in a shift toward a Th2-type cell expansion
in the alveoli (de Almeida et al., 2012), bringing about a
shift toward an alternatively activated, anti-inflammatory, M2
macrophage phenotype (Smith et al., 2008), which itself produces
more IL-10, sustaining this phenotype and a relatively more
anti-inflammatory environment. This implies that these microbes
not only alter the response of the host cell to the ingested microbe
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itself, but that it may also affect systemic signaling by the host
cell, which may affect the rate at which these bacteria are able to
spread.
Brucella and Legionella are examples of intracellular pathogens
that manipulate the endocytic pathway to create a niche in
which they can replicate and thrive. They accomplish this by
hijacking host proteins and membrane organelles to establish
a bacterium-containing vacuole with morphological features
reminiscent to that of host membrane compartments (Xu and
Luo, 2013; Celli, 2015). Effectors secreted by Brucella within
the Brucella-containing vacuole (BCV) manipulates maturation
by altering interactions with late endosomes and lysosomes
(Celli, 2015). During initial phagocytosis a large portion of
Brucella cells are rapidly degraded (∼90%), however, surviving
cells are capable of prolonged intracellular proliferation (Von
Bargen et al., 2012). Previously it was thought that Brucella
evade fusion of BCVs with lysosomes by secretion of effectors
via a functional VirB type IV secretion system (T4SS) and
cyclic β-1-2-glucan (Pizarro-Cerdá et al., 1998; Celli et al., 2003;
Arellano-Reynoso et al., 2005). Cyclic β-1-2-glucan was thought
to prevent fusion of the BCV with lysosomes by modulating
lipid raft organization on phagosome membranes, but is not a
requirement for subsequent BCV maturation (Arellano-Reynoso
et al., 2005). Rather, live cell imaging has shown that the BCV
interacts with lysosomes, thus fusion is not completely prevented
(Starr et al., 2008). Early stages of BCV maturation involve the
recruitment of late endosome markers, LAMP-1 and Rab7 to the
BCV membrane, with acidification of the BCV being crucial for
VirB expression (Boschiroli et al., 2002; Starr et al., 2008). This
early BCV is also known as the endosomal BCV (eBCV) due to its
interaction with the endocytic pathway. These findings highlight
the importance of the initial interactions with the endocytic
pathway in determining outcome. Unlike Brucella, Legionella
diverts from the canonical endocytic pathway soon after being
phagocytosed (Tilney et al., 2001). Departure from the canonical
endocytic pathway starts minutes after being phagocytosed – the
Legionella-containing vacuole (LCV) is covered with smooth
vesicles, ER in origin, and mitochondria is recruited to the LCV
(Tilney et al., 2001). The LCV is also devoid of early endosome
markers such as Rab5 and LAMP-1, with the exception of Rab7
(Roy et al., 1998). L. pneumophila utilizes early mild caspase-3
activation to prevent lysosome fusion by cleavage of rabaptin5
(effector of Rab5) (Gao and Abu Kwaik, 1999; Molmeret
et al., 2004). The eBCV and LCV both eventually interact with
components of the ER. In the case of the eBCV, LAMP-1
is progressively lost as the eBCV interacts with the ER and
maturation proceeds to the formation of a replication-permissive
BCV (rBCV) (Celli et al., 2003; Celli, 2006; Starr et al., 2008),
with the rBCV subsequently converted from an intermediate
vacuole into an ER-derived organelle which is ideal for bacterial
proliferation (Celli et al., 2003). The smooth vesicles recruited to
the LCV early on, eventually come to resemble rough ER and
become studded with ribosomes (Gerhardt et al., 2000; Tilney
et al., 2001). The specific recruitment of GTPases usually required
for fusion of ER-derived vesicles with the Golgi apparatus aids
in this process. Similar to Brucella, the hijacking of the host’s
secretory trafficking pathway results in a replication-permissive
LCV. The rapid formation of an ER-like LCV and subversion
of the endocytic pathway is dependent on the Dot/Icm T4BSS
(Defective in Organelle Trafficking/Intra-Cellular Multiplication
Type 4B Secretory System) of Legionella (Roy et al., 1998).
Indeed, mutants deficient in the T4BSS ultimately fuse with the
lysosome, indicating that effectors secreted by the T4BSS directly
influence the endocytic pathway (Roy et al., 1998; Molmeret et al.,
2004; Schroeder, 2018). The Dot/Icm T4BSS secretes hundreds of
potential virulence effector molecules that aid in the formation of
the LCV. However, no one effector has been shown to be crucial,
again indicative of multiple layers of redundancy (Schroeder,
2018). Similarly, the VirB T4SS is essential for Brucella survival,
as illustrated in virB–mutants (Hong et al., 2000; Comerci et al.,
2001; Celli et al., 2003; Pei et al., 2008). Several other pathogens
utilize T4SS and other secretion systems to release effector
molecules that are capable of manipulating host function. The
VirB and Dot/Icm systems are certainly also capable of releasing
effector molecules that, in the case of Brucella and Legionella, are
used to manipulate ER membrane dynamics and fusion.
Similar to some vacuole-inhabiting bacteria, Chlamydia
also subverts the endocytic pathway to create a replicative
niche. Chlamydia is also a very proficient modulator of
the host cytoskeleton through complex interactions of its
secreted effectors with the host cell. This manipulation is
even more interesting when considering that Chlamydia has
a relatively small genome for bacteria (1.04 and 1.23 Mb
for C. trachomatis and C. pneumoniae respectively) and
relies on the host for their metabolic requirements (Stephens
et al., 1999). Furthermore, ∼10% of its genome encodes
for virulence effectors (Betts-Hampikian and Fields, 2010)
which, as for some other intracellular pathogens, are delivered
through specialized secretion systems. Similar to Legionella, the
Chlamydia-containing inclusion (the term used for the replicative
vacuole) is diverted from the endocytic pathway early on, and is
rather trafficked to the microtubule organizing centre (MTOC)
via dynein-mediated movement. From here, they are in an ideal
position to intercept lipids and nutrient-rich exocytic vesicles.
Markers for early endocytic- and late endocytic-compartments
are absent from the inclusion (such as Rab5, Rab7 and LAMP-1)
(Rzomp et al., 2003; Scidmore et al., 2003). However, several
other Rab GTPases are recruited to the inclusion, such as Rab1,
-4, -6 (C. trachomatis only), -10 (C. pneumoniae only), -11 and
-14 (Rzomp et al., 2003; Capmany and Damiani, 2010). The
recruitment of the different Rab GTAPases is important for
the modulation of fusion events, for example the prevention
of lysosomal fusion and promoting of fusion with lipids and
nutrient-rich exocytic vesicles. Chlamydia further modulate
vesicle fusion via interaction with SNARE proteins.
Subversion of the canonical phagocytic pathway by Salmonella
uses similar mechanisms to that of, both, the vacuole-residing
bacteria and those opting for a cytosolic lifestyle. After
internalization, Salmonella remains in a modified phagosome –
the Salmonella containing vacuole (SCV). Similar to the microbes
already mentioned, Salmonella utilize secretory systems to deliver
their effectors to the host and have two T3SS encoded on different
pathogenicity islands (SPI-1 and SPI-2) (LaRock et al., 2015).
The early effectors secreted by Salmonella (via T3SS-SPI1) are
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important for the establishment of this early SCV. Shortly after
being phagocytosed SCV associates with early endosome markers
EEA-1 and Rab5 and via its effector SopB (a phosphatase), delays
lysosome fusion by indirectly preventing Rab GTPases from
binding to the phagosomal membrane (Steele-Mortimer et al.,
1999; Mallo et al., 2008; Bakowski et al., 2010). Recruitment of
sorting nexins (SNX) help in the progression of SCV maturation,
SNX1 specifically induces tubulation and is involved in the
removal of the cation-dependent mannose-6-phosphate receptor
(MPR) that may be important for the lack of lysosomal enzymes
in the late SCV (Bujny et al., 2008). Additionally, SNX3
transiently interacts with the early SCV and is required for
tubule formation and recruitment of late endosomal markers
Rab7 and LAMP-1 (Braun et al., 2010). The replacement of
early markers at this stage is accompanied by a decrease in both
bacterial cytoplasmic and SCV pH (Chakraborty et al., 2015).
This drop in pH is crucial for induction of SPI-2 genes required
for subsequent effector secretion. The effectors secreted by
T3SS-SPI-2 change the early SCV into a late SCV that is uniquely
suited for bacterial replication. Examples of SPI-2 effectors
involved in SCV maturation include SifA and SopD2. SifA
complexes with SifA-and-Kinesin-Interacting-Protein (SKIP).
The SifA-SKIP complex sequesters and binds Rab9, thereby
inhibiting Rab9-dependent recruitment of MPR (McGourty et al.,
2012). SopD2 impairs the Rab7-dependent recruitment of RILP
and FYCO1 (FYVE and Coiled-coil domain Containing protein
1). RILP and FYCO1 are involved in vesicular trafficking along
microtubules and indirect inhibition of their recruitment by
SopD2 delays delivery of the SCV to lysosomes (D’Costa et al.,
2015). At this stage, the SCV is similar to a late endosome
(with markers LAMP-1, Rab7 and V-ATPase), but not enriched
with lysosomal enzymes, possibly due to the lack of MPR and
incomplete lysosome fusion (McGourty et al., 2012). Similar
to Chlamydia, Salmonella exploit dynein-mediated transport
(via its effectors) to arrive at a juxtanuclear position near
the microtubule organizing center (MTOC). At this location,
Salmonella distinguishes itself from other intracellular pathogens
with the formation of a dynamic tubular network composed of
Salmonella induced filaments (SIFs) (Knuff and Finlay, 2017).
SIFs are required for SCV integrity, enabling continuous fusion
of host vesicles to SCV and are associated with late endosomal
markers such as LAMPs, Rab7, V-ATPase, cholesterol and
lysobisphosphatidic acid (LBPA), as well as low levels of MPR
and cathepsin D. Furthermore, another similarity with other
vacuole-living bacteria, is the communication between the SCV
and the ER, illustrating the extensive interactions of SIFs/SCV
with the host cell (Santos et al., 2015). However, unlike the other
vacuolar bacteria’s interaction with ER-derived components, the
Salmonella SCV interaction with the ER-derived coat protein
complex II (COPII) can result in SCV rupture and Salmonella
hyper-replication in the cytosol (Santos et al., 2015).
In comparison to the more meticulous modulations
mentioned, Listeria monocytogenes takes a relatively more
radical (and perhaps destructive) approach to ensure
intracellular survival. Manipulation of the clathrin-mediated
endocytic pathway facilitates entry into non-phagocytic cells
(Veiga and Cossart, 2005), whereas entry into macrophages
is achieved via phagocytosis and initial engulfment of
bacteria to form phagosomes. However, with the help of the
cholesterol-dependent pore forming toxin listeriolysin-O (LLO),
phagosome-lysosome fusion is disrupted via dysregulation of
pH and calcium gradients across the phagosome membrane
(Henry et al., 2006; Shaughnessy et al., 2006). Additionally,
with the help of two phospholipases (PlcA and PlcB), LLO
promotes escape of the bacteria from phagosomes into the
cytosol (Mitchell et al., 2015; Smith et al., 1995). Once in the
cytosol, bacteria undergo rapid growth and subsequently hijack
the host’s actin polymerization machinery to move within the
cytosol and ultimately spread in a cell-to-cell manner (Mitchell
et al., 2015; Skoble et al., 2017). Although not as intricate as
Brucella and Legionella, Listeria is also capable of slow replication
in macrophage vacuoles (instead of rapid cytosol replication)
via the formation of spacious Listeria-containing phagosomes
(SLAPs) (Birmingham et al., 2008). SLAP formation is dependent
on LLO, but unlike phagosome rupture observed with cytosolic
life, intermediate LLO expression is required for interference
with phagosomal pH, without phagosomal rupture. Bacteria
containing SLAPs are LAMP-1+, which indicates that these are
endocytic compartments. However, no drop in pH is observed,
due to LLO-mediated uncoupling of pH gradients across the
membrane and prevention of lysosome fusion. Furthermore,
SLAP formation is dependent on autophagy and is hypothesized
to be triggered by the damage caused to phagosomes by LLO.
The opportunistic pathogen Cryptococcus neoformans (Cn)
is also capable of infecting and replicating at high numbers
in macrophages and may possibly utilize these phagocytes as
shuttle for their dissemination across the blood brain barrier. An
important virulence factor of Cn is its capsule, which ensures
survival by protecting against phagocytic uptake and oxidative
stress, once infiltrated into the host circulation (Zaragoza et al.,
2008; Bojarczuk et al., 2016). However, phagocytosis can be
triggered by direct recognition of Cn capsule components or
indirectly via complement (Johnston and May, 2013). After
Cn internalization by macrophages, it resides in phagosomes
which mature into a phagolysosome, as usual. Interestingly, this
microbe does not seem to radically modulate the phagosomal
maturation process, but rather seems able to thrive at the
lower pH of the maturing phagosome. Some early- and
late-endosomal markers are present on these phagosomes,
including EEA-1, Rab5, Rab11, MPR, LAMP-1 and cathepsins,
with live Cn inducing premature removal of Rab5 and Rab11
from the Cn phagosome, which may influence phagosome
acidification (Tucker and Casadevall, 2002; Davis et al., 2015;
Smith et al., 2015). The phagolysosomes still acidify, but final
pH is maintained slightly higher, at around 5.3 (vs. normal
phagolysosome pH of ∼4.5), which is the optimal pH for Cn
growth. Additionally, damage to the phagolysosome membrane
favors Cn survival and possibly contributes to the slight increase
in pH observed with live Cn (Davis et al., 2015). Recently
urease activity was found to influence phagosomal pH, which
through production of urease-derived ammonia can increases
pH (Lerm et al., 2017; Fu et al., 2018). Furthermore, membrane
damage to the phagolysosome results in permeabilization of
the membrane and subsequent leakage of lysosomal enzymes
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(e.g., cathepsins), the loss of which may also increase survival
of Cn within the phagolysosome (Wozniak and Levitz, 2008).
Furthermore, the release of these enzymes, can result in activation
of inflammasomes and subsequent cell death (Chen et al., 2015).
It is clear that Cn is capable of modulating phagosome maturation
to some extent, but the search for responsible effectors is still
ongoing.
These studies illustrate how some pathogens manipulate the
phagocytic process in seemingly divergent ways to reach an
identical end goal of intracellular survival. In doing so they
ensure their own propagation and dissemination to elicit disease.
Importantly, in our opinion, this demonstrated susceptibility to
manipulation of the phagocytic process supports the feasibility of
drug delivery systems that harness one or more of the microbial
strategies presented here. Although there is still much research to
be done on the exact microbial effectors involved in manipulation
of the endocytic pathway, the available literature can already be
used to make informed decisions as to which effectors can be used
in the development of autologous drug delivery systems.
In the context of a complete macrophage-based drug delivery
system, the manipulation of the endocytic pathway for retention
and protection of cargo is only the first step. The next step to
consider in the development of an effective delivery system, is
the expulsion of drug cargo from macrophage vehicles. To this
end, the mechanisms used by microbes can again be mined and
possibly exploited to achieve cargo expulsion.
Expulsion From Host Cell
Turning attention now to the expulsion phase, which is a vital
requirement for pathogenic dissemination of microorganisms
and which can be induced by either the infected host cell,
or by the pathogen itself. Some microorganisms utilize host
cell machinery to facilitate their escape, while others induce
either accidental or intended host cell death, resulting in their
release from the cell as a “side-effect.” Many microorganisms
have been identified to have the ability to egress via one or
more methods and some effectors in this process have been
identified. However, in terms of manipulation of egress through
upregulation or elimination of these effectors, very little data is
available and substantial experimental work is still required in
this niche. This can be attributed, at least in part, to a large
degree of redundancy. This degree of redundancy is also seen
in the bacterial mechanisms employed to modulate phagosome
maturation, which adds complexity to the process of identifying
a controllable pathway. Below, we provide a summary of the
current knowledge regarding microbial egress, with an integrated
discussion of its potential for therapeutic application.
Probably the most obvious technique used, given the ability of
many microbes to manipulate phagosomal pH for intracellular
survival, is the manipulation of pH to induce host cell death.
This technique has been described in some detail for Mtb,
which stabilizes phagosomal pH at ∼6.2–6.5 by interfering
with the V-ATPase complex (Sturgill-Koszycki et al., 1994; Seto
et al., 2011; Queval et al., 2017). This raised pH level is a
pre-requisite for the ESX-1 dependent rupture of the phagosome
(Simeone et al., 2015). The ESX-1 (T7SS) secretory system
secretes two effector proteins, namely EsxA and EsxB, which form
a heterodimer and are secreted by Mtb in a co-dependent manner
(Renshaw et al., 2002). EsxA has membrane permeabilizing
properties and EsxB is thought to act as a chaperone to prevent
degradation and/or premature lytic activity (de Jonge et al.,
2007; Zhang et al., 2016). EsxA effects phagosome rupture and
escape to the cytosol, while being aided by the cell wall lipid
phthiocerol dimycocerosates (PDIM) (Augenstreich et al., 2017;
Quigley et al., 2017). This lipid has been proposed to primarily
aid in phagosomal rupture, resulting in increased numbers of
cytosolic bacteria – which in turn induces host cell necrosis and
ultimately Mtb dissemination (Augenstreich et al., 2017; Quigley
et al., 2017).
Other bacteria have also been described to escape through
host cell membrane rupture resulting in cell death, albeit
achieved by slightly different techniques. Brucella for example
replicates within host cells, dissociating into two phenotypes,
namely a smooth and a rough type. The rough phenotype has
cytotoxic activity which breaks down the cellular membrane
and is essential for bacterial dissemination (Pei et al., 2006,
2014). In this way, Brucella egress and dissemination is achieved
through caspase-2 mediated cell death (Chen and He, 2009;
Chen et al., 2011). Furthermore, this mode of cell death results
in a pro-inflammatory response and recruitment of additional
macrophages – that can be infected - in further aid of Brucella
dissemination (Pei et al., 2014). It has, however, been proposed
that Brucella can disseminate via cell-to-cell spread using an
autophagy related mechanism (Starr et al., 2012; Smith et al.,
2016). The final phase of Brucellosis intracellular life cycle is
the formation of an aBCV which results from the engulfment
of rBCVs into autophagosome-like structures via an autophagic
process (Starr et al., 2008, 2012). This transformation to an aBCV
is an essential prerequisite for bacterial egress via cell-to-cell
spread (Starr et al., 2012; Smith et al., 2016). Interestingly,
the VirB T4SS has been implicated in Brucella release via cell
death and cell-to-cell spread, although the bacterial effectors
have not been identified (Pei et al., 2008; Smith et al., 2016).
The different modes of dissemination are possibly due to
differences in experimental conditions, such as bacterial strains
and cell lines used. Different bacterial strains may have different
effectors or altered expression profiles that may result in different
post-replicative outcomes (i.e., cell death or cell-to-cell spread)
and different cell lines will also react differently to secreted
effectors.
Legionella can also be placed in the category of intracellular
pathogens that escape through macrophage cell death. Once
a replicative LCV is established inside the macrophage, the
bacteria converts to a replicative form and multiplies within the
enclosed LCV. At high multiplicities of infection and subsequent
termination of replication Legionella exhibit contact-dependent
cytotoxicity, resulting in formation of pores in the host cell
membranes (Kirby et al., 1998; Bachman and Swanson, 2001).
Initially pores are formed within the phagosomal membrane
(of the LCV), resulting in release of bacteria into the cytosol.
The cytosolic bacteria are then able to form pores within the
plasma membrane, resulting in osmotic lysis and release of
bacteria (i.e., necrosis) (Kirby et al., 1998; Alli et al., 2000). The
importance of the Dot/Icm secretory system of Legionella for
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pore-formation mediated lysis, and specifically that of the small
inner membrane protein, IcmT, has been illustrated (Molmeret
et al., 2002). Interestingly, in primary protozoan host cells,
Legionella is capable of non-lytic release. The bacterial effectors
LepA and LepB have been shown to play a role in manipulating
the amoeba hosts exocytic pathway for dissemination (Chen et al.,
2004, 2007). These effectors may also play a role in Legionella
release from human cells or phagosome maturation and can
potential form part of an artificial microbe drug delivery system.
Literature indicates that Salmonella exits cells via
several mechanisms, including programmed cell death and
flagella-facilitated escape. For example, the SPI-1 effector
SipB can act by inducing caspase-1-dependent pyroptosis in
macrophages (Hersh et al., 1999; Li et al., 2016). Briefly, SipB
binds to and activates caspase-1, resulting in the cleavage of
pro-IL1β and its secretion (Hersh et al., 1999; Li et al., 2016).
While this inflammatory response should result in elimination
of Salmonella, the over-activation during infection results
in release of large amounts of bacteria capable of infecting
naïve recruited cells. SipB is also able to induce apoptosis
in a caspase-1 independent manner involving activation
of caspase-2, -3, -6, and -8 (Jesenberger et al., 2000). In
addition to apoptosis and pyroptosis, Salmonella is also able
to induce oncosis in macrophages (Sano et al., 2007). Oncosis
is associated with macrophage swelling resulting in cell death,
with Salmonella-induced oncosis characterized by F-actin
dissociation. Subsequently the flagellated Salmonella escapes
from oncotic macrophages via flagellar movement (Sano et al.,
2007).
Although the methods presented here will effectively release
intracellular cargo, the associated host cell death may significantly
contribute to tissue damage and secondary inflammatory
damage, which may further delay recovery of patients. While
certainly an option to consider for further development,
specifically where cell death and increased inflammation would
not be as detrimental (e.g., cancerous tissue), a more optimal
solution in scenarios where minimization of inflammation – as
well as the availability of functional macrophages - might be more
critical, would be achieving release of drugs without the sacrifice
of host cells.
Manipulation of the host cell’s expulsion mechanics without
killing the host has indeed been described for a few microbes,
although much less information is available in this context.
From the literature, it seems that only two egress methods
have been described: direct spread into neighboring cells
and expulsion into the extracellular environment. As briefly
eluded to earlier, Listeria monocytogenes escapes from the
host phagosome into the cytosol through activity of pore
forming LLO (Alberti-Segui et al., 2007). However, complete
escape from the host macrophage is aided by the effector
responsible for modulation of the host actin polymerization
machinery. Surface anchored actin assembly-inducing protein
(ActA) interacts with the ARP2/3 complex to mediate actin
polymerization on the bacterial surface, which in turn creates
sufficient force to induce membrane protrusion and cell-to-cell
spread (Skoble et al., 2017). The actin-propelled bacteria creating
these membrane protrusions induce uptake into neighboring
cells via a process called efferocytosis (Czuczman et al., 2014).
Here, LLO damages the plasma membrane of protrusions,
resulting in surface presentation of the inner membrane leaflet
lipid, phosphatidylserine (PS) (Czuczman et al., 2014). The PS+
protrusions are recognized by the T cell immunoglobulin and
mucin-domain containing protein 4 (TIM-4) on macrophages,
which subsequently mediates the uptake of PS+ protrusions
(Czuczman et al., 2014). The bacteria may also be present in
PS+ vesicles, formed as a result of Ca2+ dependent membrane
repair and scission of the initial PS+ protrusion (Czuczman et al.,
2014). Both PS+ vesicles and protrusions are similarly taken
up by neighboring cells via TIM-4. Listeria are one of the few
phagocytically internalized microorganisms that allow host cell
survival after escape. Thus, the processes regarding expulsion of
Listeria is of great interest as target for manipulation or adoption
in therapeutic drug delivery systems.
Chlamydia is also known to exit the host cell by extrusion,
although it can also induce cell lysis (Hybiske and Stephens,
2007). These methods exhibit almost identical prevalence, but
are markedly distinct and independent. The exact bacterial
trigger facilitating either one or the other outcome has yet
to be fully elucidated. Cell lysis is known to be protease and
calcium dependant, and entails perforation of the inclusion
body (Chlamydia-containing vacuole) and plasma membrane
(Hybiske and Stephens, 2007). Chlamydia-infected host cell
lysis has been suggested to be linked to microbe-associated
apoptotic cell death, although minimal direct evidence exists in
support of this notion (Perfettini et al., 2003). Regardless, the
extrusion capability of Chlamydia from host cells without cell
lysis is of greater interest here. With this technique, inclusion
body extrusion requires actin polymerization, myosin II, RhoA
and Neuronal Wiskott-Aldrich Syndrome Protein (N-WASP)
(Hybiske and Stephens, 2007). The formation of an actin coat
around the inclusion is correlated to extrusion out of the host cell.
Host- and bacterium-derived factors play a role in the formation
of the actin coat. For example, in humans, host-derived septins
(GTP-binding proteins) form structures around the inclusion and
co-localize with F actin, resulting in the formation of F actin fibers
around the inclusion (Chin et al., 2012; Volceanov et al., 2014).
This process facilitates normal extrusion of Chlamydia inclusions
from host cells (Volceanov et al., 2014). Actin stabilization by
jasplakinolide (actin polymerization agent) alone was reported
to induce extrusion, which substantiates the role of septins in
extrusion (Hybiske and Stephens, 2007). In terms of therapeutic
application, this may suggest that the intervention achieved by
Chlamydia on the host cell mechanics may be less detrimental
to the host cell compared to other microbial exit strategies. In
a therapeutic context, this may result in faster normalization of
function in the host cell, which is much desired, as these host
cells may then be able to participate in the normal inflammatory
process that would be required for clean up after the drug has
fulfilled its function.
Non-lytic release into the extracellular space has also been
observed for Cryptococcus neoformans, albeit at low frequencies
of 5–15% in vivo (Bojarczuk et al., 2016). Autophagy has been
implicated in Cn intracellular lifestyle with components such as
Atg-2a, -5, -9a, -12 and LC3 observed in close proximity to the
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Cn containing phagosome (Qin et al., 2011; Nicola et al., 2012).
The effect of autophagy is dependent on opsonin, macrophage
type and activation state (Nicola et al., 2012). Autophagy does
seem to play a role in host defense against Cn, with disruptions
in autophagy affecting host fungistatic activity and fungal growth
(Qin et al., 2011; Nicola et al., 2012). However, this is a double
edged sword with autophagy also seemingly playing a role in
Cn release. This is evident by the observation of Atg-5-knockout
clones of J774.16 and RAW264.7 cells having reduced incidence
of non-lytic exocytosis events (Qin et al., 2011; Nicola et al., 2012).
This, along with the observation of LC3 surrounded cells outside
macrophages, suggests a possible role of autophagy in non-lytic
release of Cn (Nicola et al., 2012). Therefore, while autophagy
aids in the host defense against Cn, it also participates in the
dissemination of Cn through non-lytic release. This eludes to
a balance that must be maintained by the host with regard to
autophagy, with either decreased fungistatic activity combined
with decreased non-lytic release, or vice versa. In addition to the
potential role of autophagy in the non-lytic release of Cn, other
factors can also play a role in this route of Cn dissemination.
The increase in pH of the Cn-containing phagosome results in
increased occurrence of non-lytic release. Artificially increasing
phagosomal pH results in increased expulsion of Cn and when
compared to the in vivo situation, the damage caused by Cn to
the phagosome could result in a similar pH increase (Nicola et al.,
2011). Unfortunately, the Cn effectors responsible for non-lytic
release have not yet been elucidated. However, in addition to
the potential role of autophagy, the MAP extracellular receptor
kinase 5 (ERK5) of host cells is implicated in the regulation of
non-lytic release, with its inhibition resulting in increased release
rates (Gilbert et al., 2017). Furthermore, actin polymerization
also plays a role in release of Cn from the host (Johnston and
May, 2010). In contrast to other pathogens such as Listeria and
Chlamydia, actin polymerization inhibits Cn release through
actin flashes on the Cn containing phagosome (Johnston and
May, 2010). Although some information regarding the non-lytic
release of Cn is available, it still remains poorly understood and
the exact mechanism for this escape method is still elusive.
The body of research investigating intracellular pathogens
and their host-interacting mechanisms is significant. However,
specific information on the microbial effectors is still largely
lacking, probably owing to the fact that the main focus
of research was the prevention of these microbial actions,
rather than full elucidation thereof for implementation. In
addition, effectors secreted by invading microbial forces
exhibit a large degree of built in redundancy, so that it
is not surprising that the task of identifying specific roles
for specific effectors has remained largely unaccomplished.
Specifically, in terms of microbial expulsion, information
is largely lacking, with only a handful of known microbial
effectors. Considering this, clearly a new approach is required.
The recent advancements in gene editing, heterologous
expression, live cell imaging and -omics technologies may
provide a more powerful platform from which to investigate
the complex host-pathogen interaction and the effectors
involved, especially in the context of expulsion from immune cell
hosts.
THE IMPOSSIBLE MADE POSSIBLE?
From our review of the literature, we propose that most of the
limitations of current drug delivery systems can be overcome
by harnessing microbial strategies. We hypothesize that the
synthetic microbe drug delivery system we describe here would
(a) address poor drug-delivery to target tissue – especially at sites
with low blood supply – (b) increase treatment efficacy with lower
treatment doses and thereby (c) reduce adverse host reactions.
A visual representation of the proposed system is provided in
Figure 2.
In terms of the system we propose, we foresee two novel
preparatory steps to be done in parallel. Firstly, monocytes should
be isolated from peripheral blood collected from individuals
with a requirement for drug delivery, to enable autologous
re-infusion. These macrophages can then be propagated in
culture, differentiating and polarizing them into M1 phenotype
macrophages, as previously described (Mia et al., 2014), to
achieve the phenotype known to be most capable of translocating
FIGURE 2 | Continued
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FIGURE 2 | Visual representation of the proposed system. (A) Simultaneous
preparation of the synthetic microbes (1) and autologous macrophages (2) are
followed by introduction of the synthetic microbe into phagosome maturation
arrested macrophages (3). The complete system can now be administered
into circulation for in vivo delivery. (B) Intracellular events for in vitro engulfment
of synthetic microbe (3), in vivo maintenance/expulsion (4–7) and final delivery
of drug at target site (8–9).
out of circulation and into tissue (Arnold et al., 2007; Africa and
Smith, 2015a,b). In order to prevent intracellular degradation,
polarized macrophages can be treated to achieve transient
phagosome maturation arrest, by in vitro exposure to arresting
agents such as Wortmannin, Concanamycin A and Chloroquine,
which we have previously successfully illustrated (Visser and
Smith, 2018). The fact that phagosome maturation arrest is
achieved by in vitro intervention is a strength of this model, as this
eliminates patient exposure to these potentially harsh chemicals
and their related adverse effects. Secondly, the drug should be
packaged in multiple layers of nanoparticle coatings (Figure 2A).
These layers will serve to protect the drug from degradation,
and can be peeled away in sequential, controlled steps to achieve
controlled expulsion and release of the drug after delivery at
its required site. With advancements in polymer sciences, smart
polymers can be designed that have effectors conjugated to the
polymers and can also be developed for directed multiphasic
release of effectors at certain checkpoints. (The nature of the
different layers will be clarified in the discussion of the expulsion
phase and illustrated in Figure 2).
To construct the synthetic microbe drug delivery system,
phagosome maturation arrested macrophages will engulf
opsonized nanoparticle-enclosed drugs (the synthetic microbe)
and form a phagosome containing this cargo (Figure 2). The
number of synthetic microbes taken up per macrophage may
be optimized by adjusting macrophage-microbe exposure
time. Uptake is largely dependent on particle proximity to the
macrophage as well as size and shape of particles (Beningo and
Wang, 2002; Champion and Mitragotri, 2006; Underhill and
Goodridge, 2012). Determining the exact onset of engulfment,
following introduction of particles into cell media, is complex
and may need optimization on a case-specific basis. Unpublished
data from our group suggests initiation of engulfment to occur
within 5 min, with particles included at a 1:4 ratio with cells.
From the literature, the last stage of phagosome maturation
(phagolysosome biogenesis) occurs around 1 h after engulfment
(Jahraus et al., 1998). Our implementation of an arbitrary
exposure time of 1 h resulted in significant 4.5 µm particle
engulfment (>1 particle per cell, in ∼70% of cells) by both
arrested and untreated macrophages. Since macrophages are
capable of repeated engulfment cycles (irrespective of arrest),
carrier cells should be removed from drug-containing media
and washed after the appropriate engulfment period, to prevent
overloading of macrophages and potentially compromising
their ability to traverse endothelial barriers, as well as eventual
cell death (if particle load exceeds cytosol volume or steric
hindrance causes membrane rupture during transmigration)
(Champion and Mitragotri, 2006; Visser and Smith, 2018). At
this point, the drug-loaded macrophages are ready for autologous
re-administration into the patient via infusion into the peripheral
circulation (Figure 2B).
As stated earlier, macrophage migration to sites for delivery
will rely on the inherent macrophage capacity for chemotactic
mobility. However, in vivo testing of the system will elucidate
whether further optimization is required. Upon arrival at
the site for delivery, controlled expulsion of the cargo and
subsequent release of the drug will be achieved through
multiple consequential steps. Specifically, the phagosome lysing
and membrane escaping agents (i.e., microbial effectors)
would be released upon arrival at target location. This can
only be achieved after transient phagosome maturation has
expired and phagolysosomal degradation agents activate this
layer. This biphasic layer would, in turn, allow escape of
cargo into the cytosol, as well as expulsion thereof into
the extracellular environment through microbial effectors. The
substantial amount of genome data currently available should
enable relatively comprehensive genomic data mining for novel
and existing microbial effectors. The use of genome mining in
this context will only be useful if information (e.g., homology
regions, structural information) about effectors are available. The
use of techniques such as proteomics along with bioinformatic
mining/analysis has been suggested as more useful tools in
combination to identify effectors (Na et al., 2015; Cheng et al.,
2017). For example, in recent studies, proteomics have been used
to identify novel effectors in Salmonella. Although proteomics
can be a useful tool in identification of effectors it is only
the first step. Next would be to heterologously express the
identified effectors. Several bacterial effectors have been expressed
in heterologous systems with success (Churchill et al., 2005;
Skoble et al., 2017; Weigele et al., 2017). Most notably, the Listeria
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effectors LLO and ActA have been recombinantly expressed,
with recombinant LLO also being used for the effective delivery
of several compounds to the cytosol of cells (Lee et al., 1996;
Mandal and Lee, 2002; Provoda et al., 2003; Stier et al., 2005;
Skoble et al., 2017). The ability to identify and express possible
effectors creates the opportunity to manipulate the host endocytic
pathway. However, these effectors need to be protected from
degradation and secreted in a sequential manner to effectively
modulate host processes.
In order to prevent asynchrony of final drug release and arrival
of synthetic microbe at the target site (i.e., release of drug at
inappropriate sites), an innocuous, bio-compatible layer, such
as PNIPAAm (mentioned above), could be incorporated. This
layer would be the inner most layer and protect the drug until
controlled drug dissemination at the required site is achieved
via external stimulus (e.g., temperature or ultrasound). In the
case of a PNIPAAm layer, final drug dissemination can be
achieved by temperature increase (Feng et al., 2014). In addition,
microbubbles could also be incorporated as protective drug
micelle, instead of PNIPAAm. These microbubbles would then
be degraded by external ultrasound stimulation (Huang et al.,
2015; Lv et al., 2016; Fan et al., 2018). This layer should ideally
consist of non-biodegradable but bio-compatible constituents, to
prevent drug release into circulation and exposure to off-target
tissue. Furthermore, augmented host protection can be achieved
by allowing the safe extrusion of intact drug-micelles through the
urinary tract.
The redundancy employed in the aforementioned approach is
another characteristic that could be adopted from the plethora of
redundancy employed by microbes during immune evasion, in
order to maximize control over drug delivery and minimize risk
of undesired effects.
POST-DELIVERY CLEARANCE OF THE
SYSTEM
Given the potential complication of polymer accumulation
in vivo, or premature drug release, it is perhaps relevant to
briefly discuss safety aspects of this system. The utilization of
M1 macrophages would be advantageous as they would remain
at target locations post-delivery and could potentially contribute
to faster resolution of either primary inflammation (present due
to the disease state) or secondary inflammation (required to
clear bacterial debris after effective treatment). In support of
this theory, the M1/M2 phenotype presents with some plasticity
as tissue resident macrophages have been shown to change
phenotype following appropriate effector exposure or systemic
infection and activation by pathogens (Arnold et al., 2007;
Mills, 2012). This low risk feature is the result of the non-lytic
mechanisms employed to achieve expulsion, which is novel.
In terms of clearance of the components of the nanoparticle
layers themselves, polymeric nanoparticles have demonstrated
clearance rates of hours to several days (Alexis et al., 2008;
Feng et al., 2014). Macrophages failing to reach their intended
target sites may still release the encapsulated drug, but final
dissemination of drugs at unintended sites is unlikely, due to
the requirement for external stimulus. Thus, encapsulated drugs,
polymeric debris and loaded macrophages should be efficiently
cleared from the system, so that no long-term implications due to
residual drugs or synthetic microbe components are expected.
Clearly, a model proposing quite significant paradigm shifts,
such as the one we described here, requires substantial in vitro
and in vivo testing and optimization by multiple laboratories.
Given the requirement for in vivo tracking of cells, a zebrafish
model may be the ideal choice for pilot studies, as the basic
anatomy of the fish facilitates leukocyte migration tracking
(Langenau et al., 2004) and this model has been employed in
the context of macrophage migration (Wang et al., 2016; Barros-
Becker et al., 2017). Additionally, in vivo tracking can also be
achieved by permanent intracellular cell labeling and/or lasing
techniques (Schubert et al., 2015) that would elucidate the exact
location of carrier macrophages as well as their cargo over an
extended period of time.
CONCLUSION
Intracellular pathogens have developed a unique arsenal of tools
to evade the immune system and thrive within host cells. The
modulation of host processes, specifically modulation of the
endocytic pathway, not only make these pathogens difficult
to treat and dangerous, but also provides the opportunity to
utilize and modify their methods for human gain. If the right
combination of these effectors are repurposed, they can be used
to develop a macrophage-based delivery system for the transport
and controlled delivery of therapeutic agents packaged into a
“synthetic microbe” as described here, to significant benefit of
patients currently struggling with diseases at non-accessible sites
or those caused by multi-drug resistant pathogens.
The success of a host-derived or biological delivery system is
dependent on a key understanding of how microbial effectors
work and what combination would result in effective release
without severe side-effects, keeping in mind that the effectors
are indeed potent virulence factors. Advancements in molecular
biology, -omics, bioinformatics and live cell imaging have
resulted in the identification of effectors and their roles in the
host-microbe/pathogen interaction, using and building on this
information, effectors can be chosen that would result in the
desired outcome. Utilizing synthetic biology and heterologous
expression, effectors can be produced and tailored for specific
functions. Although some developmental steps for the proposed
synthetic microbe drug delivery model remains to be addressed
in more detail, we believe that rapid development in e.g., polymer
design and the aforementioned advancements in techniques that
are used to characterize and tailor effectors, can be used to
overcome these limitations in the very near future.
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